Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma.
Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma. Clin Cancer Res. 2016 Nov 15; 22(22):5461-5471.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Antineoplastic Agents
B7-H1 Antigen
Carcinoma, Renal Cell
Chemokine CXCL10
Chemokine CXCL9
Everolimus
Female
Humans
Immunologic Factors
Interferon-gamma
Kidney Neoplasms
Lymphocytes
Male
Middle Aged
Prospective Studies
Tumor Microenvironment
Up-Regulation
authors with profiles
Walter M. Stadler